Padmanabh P. Bhatt
Technik-/Wissenschafts-/F&E-Leiter bei SUPERNUS PHARMACEUTICALS, INC.
Vermögen: 251 187 $ am 30.04.2024
Profil
Dr. Padmanabh P.
Bhatt is a Chief Scientific Officer & Senior Vice President at Supernus Pharmaceuticals, Inc. Dr. Bhatt was previously employed as a Vice President-Advanced Drug Delivery by Shire Laboratories, Inc., a Chief Technology Officer by POINT Biomedical Corp., a Director-Technical Development by ALZA Corp., a Principal by Dow Corning Corp., and a Senior Scientist by Hercon Laboratories Corp.
He received his undergraduate degree from the University of Mumbai, a graduate degree from the University of Kansas, a graduate degree from the University of Mumbai and a doctorate degree from the University of Kansas.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.04.2024 | 8 570 ( 0,02% ) | 251 187 $ | 30.04.2024 |
Aktive Positionen von Padmanabh P. Bhatt
| Unternehmen | Position | Beginn |
|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 25.04.2012 |
Ehemalige bekannte Positionen von Padmanabh P. Bhatt
| Unternehmen | Position | Ende |
|---|---|---|
Shire Laboratories, Inc.
 Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Shire Laboratories was a specialty pharmaceutical company focused on developing products for its own portfolio and in partnership with other companies, using its technologies and development capabilities. The company products include CollaGenex, Indevus, Shire and United Therapeutics. Its key technologies are ProScreen, OptiScreen , Microtrol, Solutrol and EnSoTrol, for bioavailability enhancement and oral controlled release, and Avert for reduced-abuse potential. Shire Laboratories was headquartered in Rockville, MD. | Corporate Officer/Principal | 01.01.2005 |
POINT Biomedical Corp.
 POINT Biomedical Corp. Pharmaceuticals: MajorHealth Technology POINT Biomedical Corp. develops biomedical-imaging products. It manufactures products for diagnostic, molecular imaging, and drug delivery applications based on biSphere technology. The company was founded in 1996 and is headquartered in San Carlos, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2003 |
| ALZA CORPORATION | Corporate Officer/Principal | 01.01.2001 |
Dow Silicones Corp.
 Dow Silicones Corp. Chemicals: SpecialtyProcess Industries Dow Silicones Corp. engages in the provision of silicones products and solutions. Its silicon-based materials are used in products and applications of sectors including electronics, automotive, construction, textiles, and healthcare. The company was founded in 1943 and is headquartered in Midland, MI. | Corporate Officer/Principal | 01.01.1996 |
| Hercon Laboratories Corp. | Corporate Officer/Principal | 01.01.1992 |
Ausbildung von Padmanabh P. Bhatt
| University of Kansas | Doctorate Degree |
| University of Mumbai | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Dow Silicones Corp.
Dow Silicones Corp. Chemicals: SpecialtyProcess Industries Dow Silicones Corp. engages in the provision of silicones products and solutions. Its silicon-based materials are used in products and applications of sectors including electronics, automotive, construction, textiles, and healthcare. The company was founded in 1943 and is headquartered in Midland, MI. | Process Industries |
| Hercon Laboratories Corp. | |
Shire Laboratories, Inc.
Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Shire Laboratories was a specialty pharmaceutical company focused on developing products for its own portfolio and in partnership with other companies, using its technologies and development capabilities. The company products include CollaGenex, Indevus, Shire and United Therapeutics. Its key technologies are ProScreen, OptiScreen , Microtrol, Solutrol and EnSoTrol, for bioavailability enhancement and oral controlled release, and Avert for reduced-abuse potential. Shire Laboratories was headquartered in Rockville, MD. | Commercial Services |
POINT Biomedical Corp.
POINT Biomedical Corp. Pharmaceuticals: MajorHealth Technology POINT Biomedical Corp. develops biomedical-imaging products. It manufactures products for diagnostic, molecular imaging, and drug delivery applications based on biSphere technology. The company was founded in 1996 and is headquartered in San Carlos, CA. | Health Technology |
ALZA Corp.
 ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
